Feladilimab (GSK3359609) is a humanized IgG4 monoclonal antibody that functions as an agonist targeting ICOS (CD278). This antibody selectively binds to ICOS-expressing T cells, a critical interaction in the modulation of immune responses. Due to its mechanism of action, Feladilimab is primarily investigated for its potential applications in cancer research, where it may influence T cell activity and tumor immune evasion.
Feladilimab (GSK3359609) is a humanized IgG4 monoclonal antibody that functions as an agonist targeting ICOS (CD278). This antibody selectively binds to ICOS-expressing T cells, a critical interaction in the modulation of immune responses. Due to its mechanism of action, Feladilimab is primarily investigated for its potential applications in cancer research, where it may influence T cell activity and tumor immune evasion.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula: